Phosphatidylinositol 3-kinase/Akt signaling pathway mediates acupuncture-induced dopaminergic neuron protection and motor function improvement in a mouse model of parkinson's disease

International Journal of Neuroscience

Volumn 121, Issue 10, 2011, Pages 562-569

  Kim, Seung Nam ^a   Kim, Seung Tae ^b   Doo, Ah Reum ^a   Park, Ji Yeun ^a   Moon, Woongjoon ^a   Chae, Younbyoung ^a   Yin, Chang Shik ^a   Lee, Hyejung ^a   Park, Hi Joon ^a  

^a Kyung Hee University   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

1 methyl 4 phenyl 1 2 3 6 tetrahydropyridine; Acupuncture; Intranasal administration; Phosphatidylinositol 3 kinase Akt signaling

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 2 MORPHOLINO 8 PHENYLCHROMONE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B;

ACUPUNCTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME ACTIVATION; MALE; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PARKINSON DISEASE; RANDOMIZED CONTROLLED TRIAL; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

ACUPUNCTURE; ACUPUNCTURE POINTS; ADMINISTRATION, INTRANASAL; ANIMALS; CHROMONES; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED C57BL; MORPHOLINES; MOTOR ACTIVITY; MPTP POISONING; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-JUN; ROTAROD PERFORMANCE TEST; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 80053268796     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2011.591515     Document Type: Article

References (36)

1. Aleyasin, H., Rousseaux, M. W., Marcogliese, P. C., Hewitt, S. J., Irrcher, I., Joselin, A. P., et al. (2010).DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway. Proc Natl Acad Sci U S A, 107(7), 3186-91
2. Chae, Y., Lee, H., Kim, H., Kim, C. H., Chang, D. I., Kim, K. M., et al. (2009). Parsing brain activity associated with acupuncture treatment in P rkinson's diseases. Mov Disord, 24(12), 1794-802
3. Choi, Y. G., Park, J. H., Lim, S. (2009). Acupuncture inhibits ferric iron deposition and ferritin-heavy chain reduction in an MPTPinduced parkinsonism model. Neurosci Lett, 450(2), 92-6
4. Cristian, A., Katz,M., Cutrone, E.,Walker, R. H. (2005). Evaluation of acupuncture in the treatment of Parkinson's disease: a doubleblind pilot study. Mov Disord, 20(9), 1185-8 (Pubitemid 41632206)
5. Crocker, S. J., Smith, P. D., Jackson-Lewis, V., Lamba,W. R., Hayley, S. P., Grimm, E., et al. (2003). Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J Neurosci, 23(10), 4081-91 (Pubitemid 36958427)
6. De Rosa, R., Garcia, A. A., Braschi, C., Capsoni, S., Maffei, L., Berardi, N., et al. (2005). Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. Proc Natl Acad Sci U S A, 102(10), 3811-6 (Pubitemid 40360709)
7. Gozes, I. (2001). Neuroprotective peptide drug delivery and development: potential new therapeutics. Trends Neurosci, 24(12), 700-5 (Pubitemid 33097536)
8. Grunblatt, E., Mandel, S., Youdim, M. B. (2000). Neuroprotective strategies in Parkinson's disease using the models of 6-hydroxydopamine and MPTP. Ann N Y Acad Sci, 899, 262-73 (Pubitemid 30352792)
9. Hirsch, E. C., Faucheux, B. A. (1998). Iron metabolism and Parkinson's disease. Mov Disord, 13 Suppl 1, 39-45
10. Hirsch, E. C., Hunot, S., Damier, P., Faucheux, B. (1998). Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration? Ann Neurol, 44(3 Suppl 1), S115-20 (Pubitemid 28423837)
11. Huang, Y., Jiang, X., Zhuo, Y., Tang, A., Wik, G. (2009). Complementary acupuncture treatment increases cerebral metabolism in patients with Parkinson's disease. Int J Neurosci, 119(8), 1190-7
12. Huang, Y., Jiang, X., Zhuo, Y., Wik, G. (2010). Complementary acupuncture in Parkinson's disease: a spect study. Int J Neurosci, 120(2), 150-4
13. Hunot, S., Vila, M., Teismann, P., Davis, R. J., Hirsch, E. C., Przedborski, S., et al. (2004). JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A, 101(2), 665-70 (Pubitemid 38084694)
14. Jeon, S., Kim, Y. J., Kim, S. T., Moon, W., Chae, Y., Kang, M., et al. (2008). Proteomic analysis of the neuroprotective mechanisms of acupuncture treatment in a Parkinson's disease mouse model. Proteomics, 8(22), 4822-32
15. Kang, J. M., Park, H. J., Choi, Y. G., Choe, I. H., Park, J. H., Kim, Y. S., et al. (2007). Acupuncture inhibits microglial activation and inflammatory events in the MPTP-induced mouse model. Brain Res, 1131(1), 211-9 (Pubitemid 46053895)
16. Keith B. J., Franklin, G. P. The Mouse Brain in Stereotaxic Coordinates. California: Academic; 2008
17. Kim, S. T., Moon, W., Chae, Y., Kim, Y. J., Lee, H., Park, H. J. (2009). The effect of electroaucpuncture for 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced proteomic changes in the mouse striatum. J Physiol Sci, 60(1), 27-34
18. Kim, Y. K., Lim, H. H., Song, Y. K., Lee, H. H., Lim, S., Han, S. M., et al. (2005). Effect of acupuncture on 6-hydroxydopamine-induced nigrostratal dopaminergic neuronal cell death in rats. Neurosci Lett, 384(1-2), 133-8 (Pubitemid 40826632)
19. Lam, Y. C., Kum, W. F., Durairajan, S. S., Lu, J. H., Man, S. C., Xu, M., et al. (2008). Efficacy and safety of acupuncture for idiopathic Parkinson's disease: a systematic review. J Altern Complement Med, 14(6), 663-71
20. Liang, X. B., Liu, X. Y., Li, F. Q., et al. (2002). Long-term high frequency electro-acupuncture stimulation prevents neuronal degeneration and up-regulates BDNF mRNA in the substantia 495 nigra and ventral tegmental area following medial forebrain bundle axotomy. Brain Research Molecular Brain Research, 108(1-2), 51-59
21. Liang, X. B., Luo, Y., Liu, X. Y., et al. (2003). Electro-acupuncture improves behavior and upregulates GDNF mRNA in MFB tran-500 sected rats. Neuroreport, 14(8), 1177-1181 (Pubitemid 36930269)
22. Manning, B. D., & Cantley, L. C. (2007). AKT/PKB signaling: Navigating downstream. Cell, 129(7), 1261-1274 (Pubitemid 46962095)
23. Mouradian, M. M., Juncos, J. L., Serrati, C., et al. (1987). Exercise and the antiparkinsonian response to levodopa. Clinical Neu-505 ropharmacology, 10(4), 351-355 (Pubitemid 17113905)
24. Park, H. J., Lim, S., Joo, W. S., et al. (2003). Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model. Experimental Neurology, 180(1), 93-98 510
25. Park, Y., Chang, D., Lee, Y., et al. (2007). The Study on the Effect of Acupuncture Treatment in Patients with Idiopathic Parkinson's Disease. Journal of Korean Acupuncture Society, 24, 43-54
26. Petzinger, G. M., Walsh, J. P., Akopian, G., et al. (2007). Effects of treadmill exercise on dopaminergic transmission in the 515 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. Journal of Neuroscience, 27(20), 5291-5300 (Pubitemid 46790176)
27. Rajendran, P. R., Thompson, R. E., & Reich, S. G. (2001). The use of alternative therapies by patients with Parkinson's disease. Neu-520 rology, 57(5), 790-794 (Pubitemid 32845496)
28. Rodriguez-Oroz, M. C., Jahanshahi, M., Krack, P., et al. (2009). Initial clinical manifestations of Parkinson's disease: Features and pathophysiological mechanisms. Lancet Neurological, 8(12), 1128-1139 525
29. Rozas, G., Guerra, M. J., & Labandeira-Garcia, J. L. (1997). An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of parkinsonism. Brain Research Brain Research Protocols, 2(1), 75-84 (Pubitemid 28277496)
30. Rozas, G., Lopez-Martin, E., Guerra, M. J., et al. (1998). The over-530 all rod performance test in the MPTP-treated-mouse model of Parkinsonism. Journal of Neuroscience Methods, 83(2), 165-175 (Pubitemid 28442608)
31. Schapira, A. H. (2008). Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurological, 7(1), 97-109 (Pubitemid 350251942)
32. Shulman, L. M., Wen, X., Weiner, W. J., et al. (2002). Acupuncture 535 therapy for the symptoms of Parkinson's disease. Movement Disorders, 17(4), 799-802 (Pubitemid 41295028)
33. Wang, Y., Zhang, Y., Wei, Z., et al. (2009). JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease. Journal of 540 Neurological Sciences, 285(1-2), 172-177
34. World Health Organization Western Pacific Region. (2008). WHO Standard Acupuncture Point Locations in the Western Pacific Region. Manila: WHO Regional Office for the Western Pacific.
35. Yang, Y., Gehrke, S., Haque, M. E., et al. (2005). Inactivation of 545 Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proceedings of the National Academy of Sciences of the United States of America, 102(38), 13670-13675 (Pubitemid 41420906)
36. Yin, C. S., Jeong, H. S., Park, H. J., et al. (2008). A proposed trans-550 positional acupoint system in a mouse and rat model. Research in Veterinary Science, 84(2), 159-165 (Pubitemid 350227050)